NEW APEA PSYCH REAL EXAM, QUESTIONS AND ANSWERS WITH NGN LATEST UPDATE
If methylphenidate is contraindicated, which of the following
... [Show More] medications is recommended for treatment of ADHD in an adult?
Bupropion (Wellbutrin)
Clonazepam (Klonopin)
Fluoxetine (Prozac)
Phenelzine (Nardil) - Bupropion (Wellbutrin)
Therapeutic drug levels and predictability of clinical response are difficult to determine in first-generation antipsychotics (e.g., haloperidol [Haldol]) because they: are poorly absorbed in the intestines, hydrophilic and highly protein bound.
are highly bioavailable and poorly protein bound. have a decreased first pass effect, are hydrophilic and poorly protein bound.
have variable bioavailability, are lipophilic and highly protein bound. - have variable bioavailability, are lipophilic and highly protein bound.
Guanfacine (Intuniv), used in the treatment of attention deficit disorder, is classified as a(n): alpha-2-adrenergic agonist.
selective norepinephrine reuptake inhibitor. sympathomimetic/stimulant.
tricyclic antidepressant. - alpha-2-adrenergic agonist.
Suvorexant (Belsomra), used in the treatment of insomnia, induces sleep by: activating melatonin receptors.
blocking the signals of orexin chemicals in the hypothalamus. increasing the catabolism of tryptophan.
raising the levels of gamma-aminobutyric acid (GABA). - blocking the signals of orexin chemicals in the hypothalamus.
The mechanism of action of second-generation antipsychotic medications such as aripiprazole (Abilify) does NOT include:
5-HT2A receptor blockade.
dopamine D2 receptor blockade. serotonin reuptake stimulation.
enhanced dopamine release. - serotonin reuptake stimulation.
After initiation or increase in dose of a selective serotonin receptor inhibitor (SSRI) such as escitalopram (Lexapro), the patient should be monitored for: agitation, hypersalivation and decreased bowel sounds.
hypothermia, dilated pupils and diaphoresis. hyperthermia, akathisia and clonus.
lead pipe rigidity, hyporeflexia and tachypnea. - hyperthermia, akathisia and clonus.
Which statement about naltrexone (Vivitrol) is correct?
The patient may develop tolerance to naltrexone.
Naltrexone should be tapered once desired results are achieved.
The patient should be aware that a possible "rebound" effect may occur after discontinuation.
Naltrexone does not cause physical dependence. - Naltrexone does not cause physical dependence.
The generic name for Intuniv, used in the treatment of attention deficit disorder, is: atomoxetine. guaifenesin. guanfacine.
dextroamphetamine. - guanfacine.
A side effect NOT associated with the use of suvorexant (Belsomra) is: amnesia. cataplexy. sleep paralysis.
hypogonadism. - hypogonadism.
Ramelteon (Rozerem), a melatonin receptor agonist: is not likely to cause sleep walking or sleep driving. is safe for patients with sleep apnea. does not affect testosterone or prolactin levels. should be used with caution in patients with liver disease. - should be used with caution in patients with liver disease.
Fluvoxamine (Luvox) is approved for the treatment of: bulimia nervosa. major depressive disorder. obsessive-compulsive disorder.
panic disorder. - obsessive-compulsive disorder.
Prior to prescribing naltrexone (Vivitrol) for the treatment of opioid dependency, and periodically thereafter, the patient should be carefully monitored for: anemia. electrolyte imbalances. liver toxicity.
thrombocytopenia. - liver toxicity.
When initiating bupropion hydrochloride (Zyban), patients should be informed to stop smoking:
immediately and continue therapy for at least 4 weeks.
after the first 3 days and continue therapy for up to 4 weeks. after 5 days and continue therapy for up to 6 weeks. after 7 days and continue therapy for up to 12 weeks. - after 7 days and continue therapy for up to 12 weeks.
The drug of choice for the treatment of attention deficit disorder in children and adolescents who are overaroused and easily frustrated is: atomoxetine (Strattera). bupropion (Wellbutrin). guanfacine (Intuniv).
methylphenidate (Ritalin). - guanfacine (Intuniv). [Show Less]